These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8101962)

  • 1. [Measurement of C-erbB-2 protein in breast cancer tissue by enzyme-immunoassay: preliminary report].
    Narita T; Funahashi H; Sato Y; Imai T; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):661. PubMed ID: 8101962
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytosolic oncogenic neu protein determined with enzyme immunoassay: approximation to a marker of clinical application].
    Allende MT; Fernández Fernández M; Fernández Llana B; Ruibal A
    Rev Clin Esp; 1992 Oct; 191(6):334-5. PubMed ID: 1361681
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G; Maesawa C; Mikawa S; Satodate R
    Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of radiometric, immunometric, and immunohistochemical methods for the determination of hormonal receptors and quality control of other prognostic parameters in the characterization of carcinoma of the breast].
    Piffanelli A; Pelizzola D; Giovannini G; Catozzi L; Uccelli L; Barozzi R; Giganti M
    Pathologica; 1992; 84(1094):61-4. PubMed ID: 1363758
    [No Abstract]   [Full Text] [Related]  

  • 6. [Absence of correlation between morphometric parameters and C-erb-B2 positivity].
    Leopardi O; Colavecchio A; Colecchia M; Cannatelli G
    Pathologica; 1992; 84(1094):83-5. PubMed ID: 1363760
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma].
    Motojima K; Komuta K; Hiasa A; Tsuribune T; Hashimoto T; Tsunoda T; Kanematsu T
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):952-5. PubMed ID: 1361658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
    Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
    Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-erb B-2 protein in the sera of breast cancer patients].
    Narita T; Funahashi H; Satoh Y; Takagi H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):909-11. PubMed ID: 1351384
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
    Holm R; Abeler VM; Skomedal H; Nesland JM
    Zentralbl Pathol; 1993 Jun; 139(2):153-6. PubMed ID: 8103676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for breast cancer.
    Atkins CD
    N Engl J Med; 1994 Sep; 331(11):744; author reply 745-6. PubMed ID: 7914676
    [No Abstract]   [Full Text] [Related]  

  • 16. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. erbB-2 gene expression in colorectal cancer.
    Tsioulias GJ; Muto T; Morioka Y; Yamamoto T; Mori S
    Jpn J Exp Med; 1990 Dec; 60(6):343-9. PubMed ID: 1982887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters.
    Dittadi R; Donisi PM; Brazzale A; Marconato R; Spina M; Gion M
    Anticancer Res; 1992; 12(6B):2005-10. PubMed ID: 1363513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
    Freeman JW; McGrath P; Bondada V; Selliah N; Ownby H; Maloney T; Busch RK; Busch H
    Cancer Res; 1991 Apr; 51(8):1973-8. PubMed ID: 1672621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.